Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 4, 2020
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
[ Tue, Feb 04th 2020
] - WOPRAI
Mon, February 3, 2020
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
Joshua Schimmer Upgraded (BLUE) to Buy and Increased Target to $100 on, Feb 3rd, 2020
Joshua Schimmer of Evercore ISI Group, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Increased Target from $86 to $100 on, Feb 3rd, 2020.
Joshua has made no other calls on BLUE in the last 4 months.
There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $100 on, Friday, November 1st, 2019
These are the ratings of the 3 analyists that currently disagree with Joshua
- Mark Breidenbach of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $135 on, Friday, December 13th, 2019
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $160 on, Monday, December 9th, 2019
- Mani Foroohar of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $119 on, Tuesday, November 26th, 2019
